Reduction by beta-endorphin of efflux of dopamine and DOPAC from superfused medial basal hypothalamus.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism*; D000818:Animals; D003864:Depression, Chemical; D004298:Dopamine / Q000378:metabolism*; D004723:Endorphins / Q000494:pharmacology*; D005260:Female; D007031:Hypothalamus / Q000378:metabolism*; D007033:Hypothalamus, Middle / Q000378:metabolism*; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D010648:Phenylacetates / Q000378:metabolism*; D051381:Rats; D012737:Sex Factors; D001615:beta-Endorphin
D004723:Endorphins; D010648:Phenylacetates; D015102:3,4-Dihydroxyphenylacetic Acid; D009270:Naloxone; D001615:beta-Endorphin; D004298:Dopamine